Received Feb 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 2 | — | — |
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 3 | UNK | — |
she never came back for the 3rd dose; 2nd on 19July2023; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 69-year-old female patient who received HBV (Engerix B) for prophylaxis. Co-suspect products included HBV (Engerix B) for prophylaxis. Previously administered products included Engerix (received 1st dose of Engerix on 12th July 2022). On an unknown date, the patient did not receive the 3rd dose of Engerix B. On 19-JUL-2023, the patient received the 2nd dose of Engerix B. On 19-JUL-2023, not applicable after receiving Engerix B and an unknown time after receiving Engerix B, the patient experienced drug dose administration interval too long (Verbatim: 2nd on 19July2023). On an unknown date, the patient experienced incomplete course of vaccination (Verbatim: she never came back for the 3rd dose). The outcome of the incomplete course of vaccination and drug dose administration interval too long were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 10-JAN-2025 The reporter reported that a patient received the 1st and 2nd dose of Engerix-B in year 2023. She never came back for the 3rd dose. And now, she was on dialysis and Engerix-B dose in adult formulation was 1 ml given in 0, 1 and 6 months but adult dialysis patient got 2 ml and doing 4 times. She did received 1 ml twice in year 2023, she never completed the 3rd dose. The 1st dose was received on 12th July 2022 and 2nd dose was received on 19th July 2023, which led to Drug dose administration interval too long. Till the time of reporting, the patient did not receive 3rd dose of Engerix B, which led to incomplete course of vaccination.